| scholarly article | Q13442814 |
| P50 | author | Thor Ueland | Q12006168 |
| Michael Stumvoll | Q30434795 | ||
| Jo Røislien | Q43233382 | ||
| Kristin Godang | Q79103056 | ||
| P2093 | author name string | J Hjelmesæth | |
| J Bollerslev | |||
| T Jenssen | |||
| D Hofsø | |||
| R Sandbu | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery | Q80405239 | ||
| Weight loss therapy improves pancreatic endocrine function in obese older adults | Q33565059 | ||
| Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention | Q34178727 | ||
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin | Q34335548 | ||
| Type 2 diabetes: principles of pathogenesis and therapy | Q36095054 | ||
| Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery | Q36148290 | ||
| Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes | Q36755303 | ||
| First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. | Q37105136 | ||
| Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects | Q43233324 | ||
| Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times | Q43584254 | ||
| Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans | Q43869377 | ||
| Improved beta-cell function after standardized weight reduction in severely obese subjects | Q44295533 | ||
| Diet-induced weight loss is associated with an improvement in beta-cell function in older men. | Q44924299 | ||
| A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function | Q45242078 | ||
| Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. | Q45960720 | ||
| Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal | Q46982079 | ||
| Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight | Q47247526 | ||
| GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. | Q51481151 | ||
| Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. | Q51562839 | ||
| Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. | Q51598262 | ||
| Effect of weight loss on glucose disposal in obese and obese diabetic patients | Q69913405 | ||
| Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels | Q74487536 | ||
| P433 | issue | 2 | |
| P921 | main subject | cell function | Q95674809 |
| P304 | page(s) | 231-238 | |
| P577 | publication date | 2010-11-15 | |
| P1433 | published in | European Journal of Endocrinology | Q3060778 |
| P1476 | title | Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention | |
| P478 | volume | 164 |
| Q36134542 | All bariatric surgeries are not created equal: insights from mechanistic comparisons |
| Q55668670 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc |
| Q34075016 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soc |
| Q53671354 | Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. |
| Q38165184 | Diabetes and beta cell function: from mechanisms to evaluation and clinical implications |
| Q38109814 | Diabetes and its comorbidities--where East meets West |
| Q53765904 | Differences in Anthropometric and Metabolic Parameters Between Subjects with Hypoglycaemia and Subjects with Euglycaemia After an Oral Glucose Tolerance Test Six Months After Laparoscopic Sleeve Gastrectomy. |
| Q36292243 | Effects of bariatric surgery on glucose homeostasis and type 2 diabetes |
| Q35242025 | Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis |
| Q47094048 | European Guidelines for Obesity Management in Adults. |
| Q38405425 | Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels |
| Q47249342 | Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect |
| Q46013901 | Interdisciplinary European Guidelines on metabolic and bariatric surgery. |
| Q53102466 | Interdisciplinary European guidelines on metabolic and bariatric surgery. |
| Q38005896 | Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass |
| Q35529693 | Mechanisms responsible for excess weight loss after bariatric surgery |
| Q37022586 | Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment |
| Q47179053 | Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health |
| Q34070610 | New options for the treatment of obesity and type 2 diabetes mellitus (narrative review) |
| Q51256824 | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. |
| Q37206308 | Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management |
| Q64956935 | Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a pro |
| Q24194419 | Surgery for weight loss in adults |
| Q35132986 | Weight Loss as a Cure for Type 2 Diabetes? Fact or Fantasy |
Search more.